Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans

NCT00871325 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Ileus

Interventions

DRUG: Daikenchuto (TU-100)
DRUG: Daikenchuto (TU-100)
DRUG: Placebo

Sponsor

Tsumura USA

Collaborators

[object Object]